| Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. | |
| | |
MedLine Citation:
|
PMID: 19752325 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The remodeled vessel wall in many vascular diseases such as restenosis after injury is characterized by proliferative and apoptosis-resistant vascular smooth muscle cells. There is evidence that proproliferative and antiapoptotic states are characterized by a metabolic (glycolytic phenotype and hyperpolarized mitochondria) and electric (downregulation and inhibition of plasmalemmal K(+) channels) remodeling that involves activation of the Akt pathway. Dehydroepiandrosterone (DHEA) is a naturally occurring and clinically used steroid known to inhibit the Akt axis in cancer. We hypothesized that DHEA will prevent and reverse the remodeling that follows vascular injury. METHODS AND RESULTS: We used cultured human carotid vascular smooth muscle cell and saphenous vein grafts in tissue culture, stimulated by platelet-derived growth factor to induce proliferation in vitro and the rat carotid injury model in vivo. DHEA decreased proliferation and increased vascular smooth muscle cell apoptosis in vitro and in vivo, reducing vascular remodeling while sparing healthy tissues after oral intake. Using pharmacological (agonists and antagonists of Akt and its downstream target glycogen-synthase-kinase-3beta [GSK-3beta]) and molecular (forced expression of constitutively active Akt1) approaches, we showed that the effects of DHEA were mediated by inhibition of Akt and subsequent activation of GSK-3beta, leading to mitochondrial depolarization, increased reactive oxygen species, activation of redox-sensitive plasmalemmal voltage-gated K(+) channels, and decreased [Ca(2+)](i). These functional changes were accompanied by sustained molecular effects toward the same direction; by decreasing [Ca(2+)](i) and inhibiting GSK-3beta, DHEA inhibited the nuclear factor of activated T cells transcription factor, thus increasing expression of Kv channels (Kv1.5) and contributing to sustained mitochondrial depolarization. These results were independent of any steroid-related effects because they were not altered by androgen and estrogen inhibitors but involved a membrane G protein-coupled receptor. CONCLUSIONS: We suggest that the orally available DHEA might be an attractive candidate for the treatment of systemic vascular remodeling, including restenosis, and we propose a novel mechanism of action for this important hormone and drug. |
| | |
Authors:
|
Sébastien Bonnet; Roxane Paulin; Gopinath Sutendra; Peter Dromparis; Melanie Roy; Kristalee O Watson; Jayan Nagendran; Alois Haromy; Jason R B Dyck; Evangelos D Michelakis |
Related Documents
:
|
1827445 - Intracellular ca2+ stores in chicken purkinje neurons: differential distribution of the... 12116325 - Calcium solubility of dental enamel following sub-ablative er:yag and er:ysgg laser irr... 17113165 - Dietary phenolic antioxidants, caffeic acid and trolox, protect rainbow trout gill cell... 17981425 - Effects of ginkgolide b on 6-ohda-induced apoptosis and calcium over load in cultured p... 2165175 - Ca modulates outward current through ik1 channels. 1332495 - Single calcium channel currents of arterial smooth muscle at physiological calcium conc... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-09-14 |
Journal Detail:
|
Title: Circulation Volume: 120 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-09-29 Completed Date: 2009-10-29 Revised Date: 2011-11-02 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 1231-40 Citation Subset: AIM; IM |
Affiliation:
|
Centre de Recherche de L'Hôtel-Dieu de Québec, 9 Rue McMahon, Québec, Qc, G1R 2J6, Canada. sebastien.bonnet@crhdq.ulaval.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adjuvants, Immunologic
/
pharmacology Angioplasty, Balloon / adverse effects Animals Apoptosis / drug effects, physiology Calcium / metabolism Carotid Arteries / cytology Carotid Artery Injuries / drug therapy, metabolism, pathology Cell Division / drug effects, physiology Cell Membrane / metabolism Cells, Cultured Cytochromes c / metabolism Dehydroepiandrosterone / pharmacology* Disease Models, Animal Glycogen Synthase Kinase 3 / antagonists & inhibitors, metabolism Hexokinase / metabolism Humans Kv1.5 Potassium Channel / metabolism Male Muscle, Smooth, Vascular / cytology, drug effects, metabolism NFATC Transcription Factors / metabolism* Peripheral Vascular Diseases / drug therapy*, metabolism*, pathology Proto-Oncogene Proteins c-akt / metabolism* Rats Rats, Sprague-Dawley Voltage-Dependent Anion Channel 1 / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Adjuvants, Immunologic; 0/KCNA5 protein, human; 0/Kv1.5 Potassium Channel; 0/NFATC Transcription Factors; 0/VDAC1 protein, human; 0/Vdac1 protein, rat; 53-43-0/Dehydroepiandrosterone; 7440-70-2/Calcium; 9007-43-6/Cytochromes c; EC 1.6.-/Voltage-Dependent Anion Channel 1; EC 2.7.1.1/Hexokinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.1/glycogen synthase kinase 3 beta; EC 2.7.11.26/Glycogen Synthase Kinase 3 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chest compression fraction determines survival in patients with out-of-hospital ventricular fibrilla...
Next Document: Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surge...